• PHARMERICA CORP Financial Overview

  • Income Statement: PMC

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 1.22 B 1.85 B -634.78 M -52.12%
    Gross Profit 162.40 M 317.53 M -155.13 M -95.52%
    Net Income Before Extra Items/Preferred Div -24.10 M 15.97 M -40.07 M 166.26%
    Operating Income 27.40 M 45.97 M -18.57 M -67.77%
  • Cash Flow: PMC

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing 14.00 M 17.33 M -3.33 M -23.76%
    Net Cash Flow - Investing 22.00 M 25.01 M -3.01 M -13.67%
    Net Cash Flow/Operating Activities 36.30 M 10.03 M 26.27 M 72.36%
  • Balance Sheet: PMC

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 621.30 M 712.61 M -91.31 M -14.70%
    Total Liabilities 307.70 M 310.21 M -2.51 M -0.82%
    Shareholders Equity 309.20 M 398.79 M -89.59 M -28.97%
  • Key Ratios / Statistics: PMC

    • Valuation

      Price/Earnings (TTM) -12.28
      Price/Sales (TTM) 0.24
      Price/Book (MRQ) 2.17
      Price/Cash Flow (TTM) 9.19
    • Profitability

      Gross Margin 13.34
      Operating Margin 2.25
      Profit Margin -1.98
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.43
      Current Ratio (MRQ) 3.98
      Long Term Debt-to-Equity (MRQ) 75.61
    • Management Effectiveness

      Return on Equity (TTM) -9.63
      Return on Assets (TTM) -1.89
      Return on Investments (TTM) -3.07